Neuroendocrine neoplasia of the stomach : What is new?

Neuroendocrine Neoplasms are classified according to the new WHO classification in (1.) well differentiated neuroendocrine tumors G1 (NET G1, Ki67 ≤ 2 or mitosis count <2) and (2.) well differentiated neuroendocrine tumors G2 (NET G2, Ki67 3-20 or mitosis count 2-20) and (3.) poorly differentiated neuroendocrine carcinomas G3 (NEC G3, Ki67 > 20 or mitosis count >20). In this study 310 NENs of the Ludwig-Maximilians-University in Munich were reevaluated according to the new WHO classification. 7% of the analyzed NENs were presented as neoplasias of the stomach. In NENs of the stomach three distinct subtypes are recognized: (1) type 1 associated with autoimmune chronic atrophic gastritis (2) type 2, associated with multiple endocrine neoplasia (MEN1) and Zollinger-Ellison Syndrom; and (3) type 3, sporadic tumors. Precursor lesions (i. e. hyperplasia of the ECL cells) are found in patients with hypergastrinaemia (type 1 and 2). This article should provide insights into the diagnosis of NENs of the stomach with emphasis on the new international standard.

Citation

T Knösel, C Reiter, G Schubert-Fritschle, A Altendorf-Hofmann, T Kirchner. Neuroendocrine neoplasia of the stomach : What is new? Der Pathologe. 2017 Mar;38(2):98-104

PMID: 28188377

search → result